The manifesto - ‘Securing the Opportunity for UK Life Sciences by 2022’ - launched at the ABPI Annual Conference in London on 27 April 2017 - sets out the industry’s three priorities to improve the use of medicines and grow the UK’s status as a global hub for life sciences and pharmaceuticals.
New analysis from Fraser of Allander Institute (FAI) that maps out the economic contribution of Scotland’s pharmaceutical sector.
The Association of British Pharmaceutical Industry (ABPI) welcomes the strong focus on science and innovation in the Government's green paper on Industrial Strategy, set out today by the Prime Minister. This is further demonstration of their support for research and development which is a...
The Life Sciences Industrial Strategy, supported by Government and led by Sir John Bell, has been launched today in Birmingham.
Pharmaceutical companies are increasingly working in partnership with other firms, academia, and catapults through collaborative models, in the search to discover and develop new medicines, says a new report out today.
Andy Evans, Macclesfield Site Manager at AstraZeneca and Chair of the Medicines Manufacturing Industry Partnership has responded to the proposal in the Budget for investment in medicine manufacturing technologies.
Parliamentary Under-Secretary of State at the Department for Business, Energy and Industrial Strategy, Lord Prior of Brampton, has today visited AstraZeneca’s Macclesfield Pharmaceutical Manufacturing Facility.
Following new Fraser of Allander Institute (FAI) analysis that maps out the economic contribution of Scotland’s pharmaceutical sector, the new Director of ABPI Scotland has called upon the Scottish Government to continue to support and prioritise strategic investments in Scotland’s research,...